№ files_lp_3_process_9_37628
File format: docx
Character count: 2032
File size: 856 KB
Laboratory procedural protocol describing IgG antibody panel testing, specimen requirements, quality control measures, and result reporting for the Immucor Galileo Echo automated immunohematology analyzer.
Instrument:
Immucor Galileo Echo
Test Panels:
Capture-R Ready-ID; Capture-R Extend I; Capture-R Extend II
Test Method:
IgG antibody panel using Capture-R technology
Temperature:
37°C
Specimen Type:
EDTA anticoagulated whole blood; serum from fully clotted blood
Specimen Stability:
≤5 days from collection; ≤4 days for recently transfused or pregnant patients
Exclusion Criteria:
Hemolyzed (≥3+), lipemic, or icteric samples not accepted
Reagents:
Capture LISS; Capture-R Ready-ID; Capture-R Extend I & Extend II; Capture-R Indicator Cells; WB corQC; PHIX buffered saline
Equipment:
Immucor Galileo Echo
Quality Control:
Commercial WB corQC performed daily; 24-hour control interval after validation
Controls:
Positive and negative controls included in each 14-cell panel
Related Policy:
SWIM manual NRT.007 “Antibody Identification of Warm Reactive Antibodies”
Reporting:
Results reviewed and confirmed by technologist; specimens forwarded for additional antibody testing if required
Restrictions:
Partially used strips cannot be reused
References:
Galileo Echo Operator Manual; SWIM manual
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
N/A
Region / City:
N/A
Subject:
Instrument Maintenance
Document Type:
Protocol
Organization / Institution:
N/A
Author:
N/A
Target Audience:
N/A
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
N/A
Region / City:
N/A
Subject:
Maintenance
Document Type:
Procedure
Organization / Institution:
Immucor
Author:
N/A
Target Audience:
Administrative user, MLT 3, NEO key operator
Validity Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2026
Region / City:
Laboratory / Clinical Setting
Subject:
Blood group typing and donor unit confirmation
Document Type:
Laboratory Procedure Manual
Organization / Institution:
Immucor Laboratories
Author:
Laboratory Standards Committee
Target Audience:
Laboratory technologists and blood bank staff
Applicable Period:
Ongoing standard operating procedure
Approval Date:
2026-01-15
Equipment:
Immucor Galileo Echo
Reagents:
Anti-A series 1, Anti-B series 3, Anti-D series 4, Monoclonal control, CMT strips, PHIX buffered saline
Specimen Requirements:
Single segment from donor unit, spin and wash if hemolysed
Quality Control:
Daily commercial QC using WB corQC, valid results allow subsequent testing within 24-hour interval
Reporting System:
LIS (Cerner)
Journal:
World Journal of Gastrointestinal Pathophysiology
Manuscript Type:
Original Article
Study Design:
Retrospective Cohort Study
Authors:
Hyun Ah Chung; Sun-Young Lee; Hee Won Moon; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Affiliations:
Department of Internal Medicine, Department of Laboratory Medicine, and Department of Pathology, Konkuk University School of Medicine, Seoul 05030, South Korea
Corresponding Author:
Sun-Young Lee, MD, PhD
Country:
South Korea
Funding:
Supported by Konkuk University in 2015 (No. KU2015-A019-0270)
Institutional Review Board Approval:
Konkuk University School of Medicine (KUH1010625)
Clinical Trial Registration:
ClinicalTrials.gov ID: KCT0001302
Received:
December 27, 2015
Accepted:
July 11, 2016
Publication Year:
2016
Keywords:
Antibody; Helicobacter pylori; Hepatitis B; Immunoglobulin G; Pepsinogen
License:
Creative Commons Attribution Non Commercial (CC BY-NC 4.0)
Document Type:
Supplemental table
Topic:
Anti-SARS-CoV-2 spike protein IgG seroconversion
Subject:
Hematologic malignancies and healthy controls
Medical Context:
COVID-19 vaccination response
Vaccines Included:
BNT162b2; mRNA1273; Ad26.COV2.S; ChyAdOx1
Antibody Test Platforms:
Elecsys; AdviseDx Abbott; Liaison; DBS; Sero-Klir Kantaro; Beckman Coulter; Sino Biological; Meso Scale Discovery; Platelia
Countries Represented:
United States; United Kingdom; Israel; Denmark; Italy
Patient Groups:
ALL/AML; CLL; CML/MPD; MDS; WM; MM; NHL; Healthy controls
Sample Size Range per Study:
21–650 participants
Combined Healthy Control Sample Size:
729
Primary Outcome Measure:
Seroconversion rate after full vaccination
Source Basis:
Published and in-press peer-reviewed studies
Year:
2026
Region / City:
Not specified
Subject:
Clinical diagnostics, virology
Document Type:
In vitro diagnostic test instructions
Organization:
ZEUS Scientific, Inc.
Author:
Not specified
Target Audience:
Laboratory personnel
Period of Use:
Ongoing
Date of Issue:
2026
Safety Precautions:
Biosafety Level 2, toxic and irritant reagents handling instructions included
Components:
Microplate strips, conjugate, controls, calibrator, diluent, substrate, stop solution, wash buffer
Intended Sample:
Human serum
Test Principle:
ELISA detection of IgG antibodies to EBV Nuclear Antigen 1 (EBNA-1)
Assay Procedure:
Three-step incubation with antigen-coated wells, conjugate, and substrate followed by photometric measurement
Year:
2022
Region / city:
Italy, United Kingdom
Topic:
Sero-epidemiology, Multiple Sclerosis, Herpesviruses
Document type:
Research Protocol
Organization / institution:
N/A
Author:
Bruno Gran, Peter Maple, Chris Tench
Target audience:
Researchers, Medical professionals
Duration:
N/A
Approval date:
05 September 2022
Modification date:
N/A
Note:
Year
Year:
2018
Region / City:
EU
Theme:
Security Requirements for Handling EUCI
Document Type:
Tender Specifications
Authority:
European Union Agency for the Space Programme (EUSPA)
Author:
EUSPA
Target Audience:
Contractors and Subcontractors
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
N/A
Region / City:
N/A
Subject:
Instrument Maintenance
Document Type:
Protocol
Organization / Institution:
N/A
Author:
N/A
Target Audience:
N/A
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
N/A
Region / City:
N/A
Subject:
Immunohematology, Blood Testing, Laboratory Automation
Document Type:
User Manual / Operating Procedure
Organization:
Immucor
Equipment:
Galileo Echo
Specimens:
EDTA whole blood, ACD, CPD, CPDA-1, CP2D, heparin, AS-1, AS-3, AS-5
Reagents:
Anti-A, Anti-B, Anti-D series, Monoclonal control, Reverse A1 and B cells, Capture LISS, DAT control cells, CMT strips, Capture-R Ready reagents, Indicator Cells, WB corQC, PHIX
Quality Control:
Daily QC on ABD mono & reverse grouping and Capture-R Ready Screen strips
Maintenance:
Daily initialization and maintenance, incubator pre-warming 30 minutes before assays
Sample Requirements:
Minimum 250 µL packed RBCs for assays requiring red blood cells, 500 µL plasma or serum for assays requiring plasma or serum
Safety Notes:
Avoid testing hemolyzed, lipemic, or icteric samples; Follow reagent handling and expiration guidelines
Reference:
Galileo Echo Operator Manual
Year:
N/A
Region / City:
N/A
Subject:
Maintenance
Document Type:
Procedure
Organization / Institution:
Immucor
Author:
N/A
Target Audience:
Administrative user, MLT 3, NEO key operator
Validity Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2026
Region / City:
Laboratory / Clinical Setting
Subject:
Blood group typing and donor unit confirmation
Document Type:
Laboratory Procedure Manual
Organization / Institution:
Immucor Laboratories
Author:
Laboratory Standards Committee
Target Audience:
Laboratory technologists and blood bank staff
Applicable Period:
Ongoing standard operating procedure
Approval Date:
2026-01-15
Equipment:
Immucor Galileo Echo
Reagents:
Anti-A series 1, Anti-B series 3, Anti-D series 4, Monoclonal control, CMT strips, PHIX buffered saline
Specimen Requirements:
Single segment from donor unit, spin and wash if hemolysed
Quality Control:
Daily commercial QC using WB corQC, valid results allow subsequent testing within 24-hour interval
Reporting System:
LIS (Cerner)
Year:
2023
Region / City:
Virginia
Subject:
Psychology
Document Type:
Syllabus
Institution:
Galileo High School
Author:
Mrs. Conner
Target Audience:
High school students
Period of Validity:
2023-2024 academic year
Date Approved:
Not specified
Date of Changes:
Not specified
Year:
YYYY
Region / city:
Europe
Topic:
Frequency band designation and protection measures
Document type:
ECC Decision
Organization / Institution:
European Conference of Postal and Telecommunications Administrations
Author:
ECC
Target audience:
Telecommunications and regulatory bodies, GNSS users, amateur radio operators
Period of validity:
Indefinite
Approval date:
DD Month YYYY
Date of last modification:
DD Month YYYY